Cargando…
Computational Design of Antiangiogenic Peptibody by Fusing Human IgG1 Fc Fragment and HRH Peptide: Structural Modeling, Energetic Analysis, and Dynamics Simulation of Its Binding Potency to VEGF Receptor
Peptibodies represent a new class of biological therapeutics with combination of peptide activity and antibody-like properties. Previously, we discovered a novel peptide HRH that exhibited a dose-dependent angiogenesis-suppressing effect by targeting vascular endothelial growth factor receptors (VEG...
Autores principales: | Ning, Lin, Li, Zhongyan, Bai, Zhengya, Hou, Shasha, He, Bifang, Huang, Jian, Zhou, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036755/ https://www.ncbi.nlm.nih.gov/pubmed/29989101 http://dx.doi.org/10.7150/ijbs.24582 |
Ejemplares similares
-
Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae
por: Jørgensen, Mathias Lindh, et al.
Publicado: (2014) -
Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance
por: Suzuki, Saori, et al.
Publicado: (2018) -
Bioengineered peptibodies as blockers of ion channels
por: Chidipi, Bojjibabu, et al.
Publicado: (2022) -
Design and In Vitro Evaluation of a Cytotoxic Conjugate Based on the Anti-HER2 Affibody Fused to the Fc Fragment of IgG1
por: Sochaj-Gregorczyk, Alicja M., et al.
Publicado: (2017) -
Leadership in HRH: remembering the future?
por: Fronteira, Inês, et al.
Publicado: (2022)